Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Though usually safe, pregnant women who had liver transplants have a higher risk of some maternal and fetal complications.
Despite new guidelines, too few infants born to mothers with hepatitis C were screened for the virus.
A new study analyzed how non-alcoholic fatty liver disease affects maternal health outcomes.
Researchers are seeking to understand why only 5% of babies born to mothers with hep C become infected.
Updated recommendation includes testing for pregnant women during each pregnancy.
The CDC calls for everyone to be tested and for all pregnant women to be tested during every pregnancy.
Just under 1% of pregnant women in the state overall up to 2% in central and western New York have hep C antibodies.
Chinese researchers studied 81 women with chronic hepatitis B who began taking Viread before pregnancy.
Wider screening would prevent liver cirrhosis, liver cancer and the need for liver transplants.
A large Canadian study found that just 2% of such women developed more severe cirrhosis within one year of delivery.
The CDC has called for treatment of opioid use disorder to include screening for hepatitis C and referral to care and treatment.
More than 20 million people worldwide contract the virus every year, which can be passed from animals to humans.
Researchers analyzed outcomes among infants with hepatitis B who did and did not receive antiviral treatment before age 1.
The U.S. Preventive Services Task Force gave the recommendation an A rating, meaning screening must be covered with no cost sharing.
In a study of pregnant women, intrahepatic cholestasis, which causes severe itching, was more common in those with fatty liver disease.
The opioid epidemic has caused an increase in the incidence of hepatitis C among women of childbearing age, Is hope on the horizon?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.